|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-adrenergic receptor responses in cardiomyocytesCellular Biochemistry Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia
1Correspondence: Baker Heart Research Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne, 8008, Victoria, Australia. E-mail: liz.woodcock{at}baker.edu.au
Phospholipase Cβ1 (PLCβ1) exists as two splice variants, PLCβ1a (150 kDa) and PLCβ1b (140 kDa), which differ only in their C-terminal sequences of 64 and 31 amino acids, respectively. The 3 C-terminal amino acid residues of PLCβ1a comprise a PDZ-interacting domain, whereas the PLCβ1b sequence has no PDZ-interacting domain but contains unique proline-rich domain 5 residues from the C terminus. PLCβ1a is localized in the cytoplasm, whereas PLCβ1b targets to the sarcolemma and is enriched in caveolae. Deletion of 3 amino acids from the C terminus of PLCβ1b did not alter its sarcolemmal localization, but deletion of the entire unique 31 amino acid sequence caused cytosolic localization. A myristoylated 10 amino acid peptide from the C terminus of PLCβ1b selectively dissociated N-terminally GFP-tagged PLCβ1b from the sarcolemma and inhibited PLC responses to
1-adrenergic agonists, with a half maximal effective concentration of 12 ± 1.6 µM (mean±SE, n=3). A similar peptide from PLCβ1a was without effect at concentrations below 100 µM. Thus, the extreme C-terminal sequences of the PLCβ1 splice variants determine localization and, thus, function. In cardiomyocytes, responses initiated by
1-adrenergic receptor activation involve only PLCβ1b, and the selective targeting of this splice variant to the sarcolemma provides a potential therapeutic target to reduce hypertrophy, apoptosis, and arrhythmias.—Grubb, D. R., Vasilevski, O., Huynh, H., and Woodcock, E. A. The extreme C-terminal region of phospholipase Cβ1 determines subcellular localization and function; the "b" splice variant mediates
1-adrenergic receptor responses in cardiomyocytes.
Key Words: proline-rich domain Gq PLC myristoylated peptides signaling specificity
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |